Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Greystone Research Associates | PRODUCT CODE: 1235287

Cover Image

PUBLISHER: Greystone Research Associates | PRODUCT CODE: 1235287

Inhaled Pain Therapeutics: Evolving Therapeutics, Emerging Opportunities

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3850
PDF (Site License)
USD 5500
PDF (Enterprise License)
USD 7500

Add to Cart

‘Inhaled Pain Management: Evolving Therapeutics, Emerging Opportunities’ is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.

The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for inhaled pain management drug therapeutics. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

User-friendly Administration for a Diverse and Growing Therapeutic Need

As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing a higher level of emphasis on pain management as a quality-of-life issue for patients and their families. Responding to this trend, drug developers are increasingly turning to inhalable formulations of pain management drugs. Because it has the potential to improve drug therapy compliance, inhaled pain drug delivery addresses a key healthcare issue - one that is particularly problematic in aging populations and developing economies. Several of these development programs involve international partnerships designed to take advantage of perceived opportunities in regional markets.

What You Will Learn:

  • Analyzes and evaluates inhaled pain management drugs currently in development and assesses the market potential for existing and probable future products.
  • Examines inhalation device technology for commercial and development-stage devices, and evaluates product technology issues and evolving market factors for inhaled pain management therapeutics.
  • Provides detailed assessments of market segments, market potential, and growth prospects.
  • Forecasts the impact of new and emerging inhaled pain management drug therapeutics on healthcare markets and prescribing decisions.
  • Profiles Inhaled pain management drug product market participants, their technology, product development activity, and business strategies.
  • Evaluates the impact of economic, technology, and regulatory factors on market sector companies and their alliance partners.

Table of Contents

  • Inhaled Pain Management
  • Executive Summary
  • The Pain Management Market Opportunity
  • Evolution in Pain Management Guidelines
  • Regional Factors in Pain Management Practice
  • Pain Management Demand Drivers
  • Competitive Landscape
  • Factors Limiting Growth
  • Inhalation Technology, Platforms and Design Factors
  • Drug Formulations
  • Formulation Technologies
  • Excipients and Release Profiles
  • Oral Inhalation Device Design Factors
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Nebulizers
  • Intranasal Inhalation
  • Intranasal Delivery Pharmacokinetics
  • Intranasal Device Characteristics
  • Performance Factors
  • Bioavailability
  • Dose Reproducibility
  • Active Compound Stability
  • Key Near-Term Pain Markets for Inhaled Drugs
  • Breakthrough Cancer Pain
  • Migraine and Cluster Headaches
  • Moderate to Severe Pain
  • 1Inhaled Pain Management Products
  • FDA-Approved Drugs
  • AstraZeneca
  • GlaxoSmithKline
  • Valeant
  • Mylan/Roxane/Apotex
  • Ketorolac
  • Development-Stage Drugs
  • Butorphanol
  • Fentanyl
  • Dihydroergotamine
  • Ketamine
  • Morphine
  • Perchlorperazine
  • Triptans
  • Market Factors
  • Usability and Patient Preferences
  • Regulatory Issues
  • Patient Compliance
  • The Role of CMOs/CSOs
  • Company Profiles
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!